---
title: "Module: History of FHIR"

bibliography: bibliography.bib

area:
  name: Overview
topic:
  name: FHIR for Research

roles:
  - Investigator
  - Informaticist
  - Software Engineer
  - Clinician Scientist/Trainee

learning_objectives:
  - question: What is terminology in health informatics?
    answer: tbd
  - question: Why is terminology important for interoperability?
    answer: tbd
  - question: What are some common terminology systems you may encounter?
    answer: tbd
  - question: How is terminology implemented in FHIR?
    answer: tbd
---

```{=html}
<!--# DISCUSS

Overall comments:

Basic content and structure look good.

1. simplify your language and remove extraneous words/sentences/modifiers.
2. add many more links - for example, in RxNorm, The first use of "RxNorm" should link to the RxNorm page. In general, first use of an external resource in a section should be linked. Check all sections and ensure linking is happening.
3. Change headings to statements rather than questions.
4. Any outstanding notes/questions should be moved in a .qmd comment (You have some "Note: <...>" stuff).
5. Use block quotes sparingly and only when the content cannot be easily summarized and is appropriate for the audience.
6. Update to follow style guide (which you already noted :))

--LDC
-->
```
## Terminology in health informatics

```{=html}
<!--# FIX
reminder to simplify your language and remove unnecessary sentences.
Our goal with these is simple and succinct.

For example:

"At its most basic definition, terminology in IT refers to a code mapping to a concept."

can be

"Terminology in Health Informatics is a mapping between a **code* and a *concept**."


"It is common in healthcare to map codes between multiple code systems to help achieve interoperability between disparate systems."

can be

"Mapping codes between code systems helps achieve interoperability between health systems."

Please go through this entire module and simplify and/or remove entire sentences where possible.

--LDC
-->
```
Terminology in Health Informatics is a mapping between a **concept** and a **code**.

-   **Concept**: mental representation of a real or abstract thing<!--# FIX what does "unitary mental representation of a real or abstract thing" mean? Rephrase and simplify. --LDC -->, e.g., a disease state or medical procedure.

-   **Code**: series of letters, numbers, or symbols assigned to one concept in a code system for the purposes of classification or identification.

A concept is a universal and may have a different code between different code systems. Mapping codes between code systems helps achieve interaperability between health systems.

[HIMSS provides a summary of terminology standards](https://www.himss.org/terminology-standards) as a way to:

> address a fundamental requirement for effective communication -- the ability to represent concepts in an unambiguous manner between a sender and receiver of information. Most communication between health information systems relies on structured vocabularies, terminologies, code sets and classification systems to represent health concepts.

<!--# You use a lot of block quotes. My take: only include large quotes where they state something different/unique from what you were saying and they say it in the best way possible. Otherwise, summarize/reframe/simplify for your audience and cite the original. -LDC -->

You might be familiar with some terminology systems like [ICD-10](https://www.cdc.gov/nchs/icd/icd10.htm)<!--# FIX add link --LDC --> for classifying diseases (and related concepts). These systems typically consist of:

1.  A machine-readable code representing a concept (like the ICD-10 code `W56.02XA`)
2.  A human-readable description of the code (for `W56.02XA`, the description is "Struck by dolphin, initial encounter")
3.  "Metadata" describing additional attributes of the concept, like parent or related concepts (`W56.02XA` is part of `W56`, which is the group of ICD-10 codes for "Contact with nonvenomous marine animal")

There are a number of other common terminology systems for classifying things like pharmaceuticals, laboratory testing, and vaccines. We will describe some of these below.

## Why terminology is important for interoperability

Standard terminology serves as the foundation for interoperability in health IT by (1) organizing complex information across a multitude of domains and (2) defining the semantics of consistent and computable information exchange between computer systems. Using standard terminologies allows researchers to access, organize, and utilize health data in a consistent and reliable way. [@himss_terminology]

The developers of FHIR were aware of the importance of translating information between these terminologies, developing multiple FHIR Resources specifically for that purpose. Before diving into how that works, we will first review some of the most common terminology systems that you as a researcher might encounter.

## Common terminology systems you may encounter

[HIMSS discusses 11 different terminology standards](https://www.himss.org/terminology-standards), however we will focus on the major 5 that you will most likely run into as a researcher. These include the following:

-   [LOINC](https://loinc.org/) (Logical Observation Identifiers Names and Codes)

-   [SNOMED CT](https://www.snomed.org/) (Systematized Nomenclature of Medicine--Clinical Terms)

-   [ICD](https://www.who.int/standards/classifications/classification-of-diseases) (International Statistical Classification of Diseases and Related Health Problems)

-   [RxNorm](https://www.nlm.nih.gov/research/umls/rxnorm/index.html) (Medical prescription Normalized)

-   [CVX](https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx) (Vaccine administered)

### LOINC

#### About

LOINC is a common language for identifying health measurements, observations, and documents. It can be thought of as representing the "question" that an observation asks, with other standards (such as SNOMED CT, described next) representing the "answer." It has been called "the global lingua franca for identifying tests and observations." [@loinc_get_started]

#### Nomenclature

A LOINC code distinguishes a given observation (test ordered, survey question, or clinical document) across six dimensions known as **Parts** [@loinc_term_basics]. The table below defines each Part as well as provides examples for the breakdown of the LOINC for a *manual count of white blood cells in cerebral spinal fluid specimen*.

+---------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+
| LOINC Part          | Definition                                                                                                                                                 | Example                        |
+=====================+============================================================================================================================================================+================================+
| Component (Analyte) | The substance or entity being measured                                                                                                                     | Leukocytes (white blood cells) |
+---------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+
| Property            | The characteristic or attribute of the analyte                                                                                                             | NCnc (Number concentration)    |
+---------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+
| Time                | The interval of time over which an observation was made                                                                                                    | Pt (Point in time)             |
+---------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+
| System (Specimen)   | The specimen or thing upon which the observation was made                                                                                                  | CSF (Cerebral spinal fluid)    |
+---------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+
| Scale               | How the observation value is quantified or expressed: quantitative, ordinal, nominal                                                                       | Qn (Quantitative)              |
+---------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+
| Method              | (Optional) A high-level classification of how the observation was made. Only needed when the technique affects the clinical interpretation of the results. | Manual Count                   |
+---------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+

The LOINC code for the above test is [`806-0`](https://loinc.org/806-0). There are three different text labels LOINC creates for a code, with definitions and examples for the test above provided below [@loinc_term_basics]:

+----------------------------+------------------------------------------------------------------+
| Text Label (Name)          | Example for [`806-0`](https://loinc.org/806-0) (test above)      |
+============================+==================================================================+
| Fully-Specified Name (FSN) | Leukocytes: NCnc: Pt: CSF: Qn: Manual count                      |
+----------------------------+------------------------------------------------------------------+
| Long Common Name           | Leukocytes \[#/volume\] in Cerebral spinal fluid by Manual count |
+----------------------------+------------------------------------------------------------------+
| Short Name                 | WBC \# CSF Manual                                                |
+----------------------------+------------------------------------------------------------------+

### SNOMED CT

#### About

SNOMED CT is a clinical terminology standard that is developed by **SNOMED International**. It can be viewed as the "answer" for a test or measurement to the LOINC "question" code. [SNOMED International further details the utility of SNOMED CT](https://www.snomed.org/five-step-briefing) below:

> SNOMED CT:
>
> -   Is the most comprehensive, multilingual clinical healthcare terminology in the world
>
> -   Is a resource with comprehensive, scientifically validated clinical content
>
> -   Enables consistent representation of clinical content in electronic health records
>
> -   Is mapped to other international standards
>
> -   Is in use in more than eighty countries

#### Nomenclature

The basic principles behind SNOMED CT are concepts, descriptions, and relationships [@snomed].

-   **Concept**: Unique clinical meaning that is referenced with a unique computer readable numeric identifier. Can have multiple descriptions.

-   **Description**: Human readable phrases that describe a concept (what a doctor would read).

-   **Relationship**: Correlation between related concepts, i.e. "synonyms." Provides computer readable definitions of concepts and allow for data to be searched for in a variety of ways.

Since healthcare workers often have different ways of saying the same thing, relationships allow synonyms to be linked together around a single concept, allowing computer systems to understand the common meaning. There are two major types of relationships:

-   **Hierarchical Relationship**: defines specific concepts as children of more general concepts; each concept has at least one hierarchical relationship

-   **Attribute Relationships**: defines non-hierarchical relationships between two concepts; each concept can have as many attribute relationships as needed

There is only one hierarchical relationship attribute: `is a`. If Concept 1 is a subset of Concept 2, they can be connected with the following statement: `Concept 1 is a Concept 2`.

There are multiple attribute relationships, depending on whether they relate to one of two groups of concepts [@snomed_aao]:

1.  Attribute relationships for diseases and disorders: `finding site`, `causative agent`, `associated morphology`
2.  Attribute relationships for medical and surgical procedures: `procedure site`, `method`, `direct morphology`, `direct device`, `using`

Below is an example how SNOMED might represent a condition and its associated relationships. A patient has acute post-streptococcal glomerulenephritis, which is then associated with a multitude of hierarchical and attribute relationships.

<!--# *NOTE: let's recreate this in HTML down the road. It is the best visual I've been able to find for showing SNOMED relationships, i got it from this snippet of a Georgia Tech Online Health Informatics MS course video. -->

```{=html}
<!--# FIX
Moving forward, include notes like this in a comment like these so we don't miss them in the final push.

--LDC
-->
```
![](images/snomed_example.png)<!--# FIX broken image link --LDC -->

### ICD

#### About

ICD is a medical classification list that contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases. [The WHO describes its major use cases](https://www.who.int/standards/classifications/classification-of-diseases) as the following:

> These data and statistics support payment systems, service planning, administration of quality and safety, and health services research. Diagnostic guidance linked to categories of ICD also standardizes data collection and enables large scale research.

WHO consistently updates ICD with new versions, with ICD-11 being the most recent version and ICD-10 currently being the most used. We will discuss the basic structure of ICD-10 in this module.

#### Nomenclature

An ICD-10 code can range between 3 and 7 alphanumeric characters and has three major parts [@icd_10]:

1.  **Category**: A three character code that always begins with one letter that is followed by two numbers. This code describes the general type of injury or disease.
2.  **Subclassification** (optional): To further specify an injury or disease, the three-character alphanumeric category code can be followed by a decimal point and up to three different levels of classification to further explain the cause, manifestation, location, severity, and type of injury or disease. This code section can be up to 3 numeric characters, with each added character adding more specificity.
3.  **Extension** (optional): This final code section is one of three letters that describe the type of encounter a given injury or disease. It will always be the 7th character and directly follows the subclassification numbers, not requiring a decimal point to separate it. It can either be A (initial encounter), D (subsequent encounter), or S (sequila).

::: {.callout-caution collapse="true"}
## Expand to view ICD-10 categories

+-----------+-----------------------------------------------------------------------------------------------------+
| Range     | Topic                                                                                               |
+===========+=====================================================================================================+
| A00-B99   | Certain infections and parasitic diseases                                                           |
+-----------+-----------------------------------------------------------------------------------------------------+
| C00-D49   | Neoplasms                                                                                           |
+-----------+-----------------------------------------------------------------------------------------------------+
| D50-D89   | Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism |
+-----------+-----------------------------------------------------------------------------------------------------+
| E00-E89   | Endocrine, nutritional and metabolic diseases                                                       |
+-----------+-----------------------------------------------------------------------------------------------------+
| F01-F99   | Mental, Behavioral and Neurodevelopmental disorders                                                 |
+-----------+-----------------------------------------------------------------------------------------------------+
| G00-G99   | Diseases of the nervous system                                                                      |
+-----------+-----------------------------------------------------------------------------------------------------+
| H00-H59   | Diseases of the eye and adnexa                                                                      |
+-----------+-----------------------------------------------------------------------------------------------------+
| H60-H95   | Diseases of the ear and mastoid process                                                             |
+-----------+-----------------------------------------------------------------------------------------------------+
| I00-I99   | Diseases of the circulatory system                                                                  |
+-----------+-----------------------------------------------------------------------------------------------------+
| J00-J99   | Diseases of the respiratory system                                                                  |
+-----------+-----------------------------------------------------------------------------------------------------+
| K00-K95   | Diseases of the digestive system                                                                    |
+-----------+-----------------------------------------------------------------------------------------------------+
| L00-L99   | Diseases of the skin and subcutaneous tissue                                                        |
+-----------+-----------------------------------------------------------------------------------------------------+
| M00-M99   | Diseases of the musculoskeletal system and connective tissue                                        |
+-----------+-----------------------------------------------------------------------------------------------------+
| N00-N99   | Diseases of the genitourinary system                                                                |
+-----------+-----------------------------------------------------------------------------------------------------+
| O00- O9A  | Pregnancy, childbirth, and puerperium                                                               |
+-----------+-----------------------------------------------------------------------------------------------------+
| P00-P96   | Certain conditions originating in the perinatal period                                              |
+-----------+-----------------------------------------------------------------------------------------------------+
| Q00-Q99   | Congenital malformations, deformations and chromosomal abnormalities                                |
+-----------+-----------------------------------------------------------------------------------------------------+
| R00-R99   | Symptoms, signs, and abnormal clinical laboratory findings, not elsewhere classified                |
+-----------+-----------------------------------------------------------------------------------------------------+
| S00-T88   | Injury, poisoning, and certain other consequences of external causes                                |
+-----------+-----------------------------------------------------------------------------------------------------+
| V00-Y99   | External causes of morbidity                                                                        |
+-----------+-----------------------------------------------------------------------------------------------------+
| Z00-Z99   | Factors influencing health status and contact with health services                                  |
+-----------+-----------------------------------------------------------------------------------------------------+
:::

Below is an example of different levels of specificity for an ICD-10 code [@icd_10]. The injury is a *closed fracture of distal phalanx of right index finger*.

-   **`S62` -- fracture at wrist and hand level**

    -   `S62.0` -- fracture at navicular \[scaphoid\] bone of wrist

    -   ...

    -   `S62.5` -- fracture of thumb

    -   **`S62.6` -- fracture of other and unspecified finger(s)**

        -   `S62.60` -- fracture of unspecified phalanx of finger

        -   `S62.61` -- displaced fracture of proximal phalanx of finger

        -   ...

        -   **`S62.63` -- displaced fracture of distal phalanx of finger**

            -   **`S62.630` -- displaced fracture of distal phalanx of right index finger**

                -   **`S62.630A` -- ... initial encounter for closed fracture**

                -   `S62.630B` -- ... initial encounter for open fracture

                -   `S62.630D` -- ... initial encounter for fracture with routine healing

### RxNorm

#### About

The NIH National Library of Medicine (NLM) produces RxNorm and [provides a summary](https://www.nlm.nih.gov/research/umls/rxnorm/index.html) of its purpose:

> RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software... By providing links between these vocabularies, RxNorm can mediate messages between systems not using the same software and vocabulary.

Its scope includes the names of prescription and many over-the-counter drugs approved for use in the US, including generic and branded medications. Outside of RxNorm's scope include substances such as bulk powders, food, dietary supplements, and medical devices.

#### Nomenclature

To understand RxNorm nomenclature, it is useful to review three major steps that NLM goes through when receiving drug names from a myriad of data sources [@rx_norm_nih].

1.  **Group source data**: When NLM receives drug names with different formats that refer to the same medication, it groups them all together and refers to them as **synonyms**. This group of synonyms is called a **concept**. Below are examples of different synonyms that all refer to the same concept:
    -   Naproxen Tab 250 MG

    -   Naproxen 250mg tablet (product)

    -   NAPROXEN\@250 mg\@ORAL\@TABLET

    -   Naproxen 250 MILLIGRAM In 1 TABLET ORAL TABLET

    -   NAPROXEN 250MG TAB,UD \[VA Product\]
2.  **Create normalized name for a concept**: After synonyms are grouped into a concept, RxNorm then creates a normalized name for it detailing the ingredient, strength, and dose form. If the drug is branded or in a pack, then those are also included. For the concept above, the RxNorm normalized name is "Naproxen 250 MG Oral Tablet." The branded version is "Naproxen 250 MG Oral Tablet \[Prosaid\]." The general format for an RxNorm normalized name is dependent on two factors: (1) generic vs. branded, and (2) single vs. pack. Below summarizes the general formats for each scenario:
    -   Generic drugs - Ingredient Strength Dose Form

    -   Branded drugs - Ingredient Strength Dose Form \[Brand Name\]

    -   Generic drug packs - {# (Ingredient Strength Dose Form) / \# (Ingredient Strength Dose Form)} Pack

    -   Branded drug packs - {# (Ingredient Strength Dose Form) / \# (Ingredient Strength Dose Form)} Pack \[Brand Name\]
3.  **Assign concept unique identifier (RXCUI)**: The RXCUI is a numeric identifier that is a code assigned to a given concept. For example, the RXCUI for the above concept example is `198013`.

RxNorm normalized names can have different levels of specificity, defined by the **term type (TTY)**. For example, depending on the TTY, an RXNorm normalized name might only include the ingredient, might only include the dose form, or one of many combinations of descriptors.

::: {.callout-caution collapse="true"}
## Expand to view the different TTYs

+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| TTY     | Name                              | Description                                                                                                                                                                                        | Example                                                                                                                                                                                                |
+:========+:==================================+:===================================================================================================================================================================================================+:=======================================================================================================================================================================================================+
| IN      | Ingredient                        | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).                                                     | Fluoxetine                                                                                                                                                                                             |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| PIN     | Precise Ingredient                | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.                                                                    | Fluoxetine Hydrochloride                                                                                                                                                                               |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MIN     | Multiple Ingredients              | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | Fluoxetine / Olanzapine                                                                                                                                                                                |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| DF      | Dose Form                         | See [Appendix 2](https://www.nlm.nih.gov/research/umls/rxnorm/docs/2018/appendix2.html) for a full list of Dose Forms.                                                                             | Oral Solution                                                                                                                                                                                          |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| DFG     | Dose Form Group                   | See [Appendix 3](https://www.nlm.nih.gov/research/umls/rxnorm/docs/2018/appendix3.html) for a full list of Dose Form Groups.                                                                       | Oral Liquid                                                                                                                                                                                            |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| SCDC    | Semantic Clinical Drug Component  | Ingredient + Strength                                                                                                                                                                              | Fluoxetine 4 MG/ML                                                                                                                                                                                     |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| SCDF    | Semantic Clinical Drug Form       | Ingredient + Dose Form                                                                                                                                                                             | Fluoxetine Oral Solution                                                                                                                                                                               |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| SCDG    | Semantic Clinical Dose Form Group | Ingredient + Dose Form Group                                                                                                                                                                       | Fluoxetine Oral Product                                                                                                                                                                                |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| SCD     | Semantic Clinical Drug            | Ingredient + Strength + Dose Form                                                                                                                                                                  | Fluoxetine 4 MG/ML Oral Solution                                                                                                                                                                       |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| BN      | Brand Name                        | A proprietary name for a family of products containing a specific active ingredient.                                                                                                               | Prozac                                                                                                                                                                                                 |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| SBDC    | Semantic Branded Drug Component   | Ingredient + Strength + Brand Name                                                                                                                                                                 | Fluoxetine 4 MG/ML \[Prozac\]                                                                                                                                                                          |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| SBDF    | Semantic Branded Drug Form        | Ingredient + Dose Form + Brand Name                                                                                                                                                                | Fluoxetine Oral Solution \[Prozac\]                                                                                                                                                                    |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| SBDG    | Semantic Branded Dose Form Group  | Brand Name + Dose Form Group                                                                                                                                                                       | Prozac Pill                                                                                                                                                                                            |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| SBD     | Semantic Branded Drug             | Ingredient + Strength + Dose Form + Brand Name                                                                                                                                                     | Fluoxetine 4 MG/ML Oral Solution \[Prozac\]                                                                                                                                                            |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| PSN     | Prescribable Name                 | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.                                                               | Leena 28 Day Pack                                                                                                                                                                                      |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| SY      | Synonym                           | Synonym of another TTY, given for clarity.                                                                                                                                                         | Prozac 4 MG/ML Oral Solution                                                                                                                                                                           |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| TMSY    | Tall Man Lettering Synonym        | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.                                                                                                   | FLUoxetine 10 MG Oral Capsule \[PROzac\]                                                                                                                                                               |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| BPCK    | Brand Name Pack                   | {# (Ingredient Strength Dose Form) / \# (Ingredient Strength Dose Form)} Pack \[Brand Name\]                                                                                                       | {12 (Ethinyl Estradiol 0.035 MG / Norethindrone 0.5 MG Oral Tablet) / 9 (Ethinyl Estradiol 0.035 MG / Norethindrone 1 MG Oral Tablet) / 7 (Inert Ingredients 1 MG Oral Tablet) } Pack \[Leena 28 Day\] |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| GPCK    | Generic Pack                      | {# (Ingredient + Strength + Dose Form) / \# (Ingredient + Strength + Dose Form)} Pack                                                                                                              | {11 (varenicline 0.5 MG Oral Tablet) / 42 (varenicline 1 MG Oral Tablet) } Pack                                                                                                                        |
+---------+-----------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
:::

### CVX

#### About

CVX is a standard terminology for both active and inactive vaccines in the US. It is developed and maintained by the CDC's National Center of Immuniczation and Respiratory Diseases (NCIRD). Inactive vaccine CVX codes allow for the analysis of historical immunization records. [@cvx]

#### Nomenclature

The CVS code set is tabular with 6 different columns:

1.  Short Description
2.  Full Vaccine Name
3.  CVX Code (2-3 numerical characters)
4.  Vaccine Status
    -   **Active:** A currently available administrable vaccine

    -   **Inactive:** An administrable vaccine formulation that is no longer available for patient administration, but can be found in historical patient records **OR** A historical record of a vaccine administered where the exact formulation is unknown

    -   **Pending:** A vaccine that is expected to become active in the future

    -   **Non-US:** A vaccine that available outside the US only

    -   **Never Active:** A vaccine that was never available and is not in the pipeline of new vaccines
5.  Last Updated Date
6.  Notes

Below is an example of the first 5 entries of the CDX code set, organized in ascending order of CVX Code:

+-------------------+---------------------------------------------------+----------+----------------+---------------+-----------------------------------------+
| Short Description | Full Vaccine Name                                 | CVX Code | Vaccine Status | Last Updated\ | Notes                                   |
|                   |                                                   |          |                | Date          |                                         |
+===================+===================================================+==========+================+===============+=========================================+
| DTP               | diphtheria, tetanus toxoids and pertussis vaccine | 01       | Inactive       | 5/28/2010     |                                         |
+-------------------+---------------------------------------------------+----------+----------------+---------------+-----------------------------------------+
| OPV               | trivalent poliovirus vaccine, live, oral          | 02       | Inactive       | 2/10/2017     | This is the OPV that was used in the US |
+-------------------+---------------------------------------------------+----------+----------------+---------------+-----------------------------------------+
| MMR               | measles, mumps and rubella virus vaccine          | 03       | Active         | 5/28/2010     |                                         |
+-------------------+---------------------------------------------------+----------+----------------+---------------+-----------------------------------------+
| M/R               | measles and rubella virus vaccine                 | 04       | Inactive       | 5/28/2010     |                                         |
+-------------------+---------------------------------------------------+----------+----------------+---------------+-----------------------------------------+
| measles           | measles virus vaccine                             | 05       | Inactive       | 8/31/2010     |                                         |
+-------------------+---------------------------------------------------+----------+----------------+---------------+-----------------------------------------+

## How terminology is implemented in FHIR

FHIR provides a [Terminology Service](https://build.fhir.org/terminology-service.html#:~:text=A%20FHIR%20terminology%20service%20is,inherently%20known%20terminologies%20providing%20support.) to allow the mapping of information between different terminology standards. It does so by defining three major terminology-related FHIR Resources: `CodeSystem`, `ValueSet`, and `ConceptMap`. The diagram below shows how these FHIR Resources can be used together to map terminology information using FHIR. The next sections will provide more information about each resource.

<!--# NOTE: this is a screenshot from the FHIR for Devs presentation. It is by far the best visual I have found on this topic, but it is definitely not the final version we should use. Down the line we should have this recreated. -->

![](images/fhir_terminology.png)

### CodeSystem

The [CodeSystem FHIR Resource](https://build.fhir.org/codesystem.html) defines an organized, managed collection of *codes* that belong to a particular terminology standard. Examples include LOINC, SNOMED CT, and the other standards discussed in the previous section. This FHIR Resource declares not only the existence of a code system, but also its key properties:

-   Identifying URL and version

-   Description, Copyright, publication date, and other metadata

-   Some key properties of the code system itself - e.g. whether it exhibits concept permanence, whether it defines a compositional grammar, and whether the codes that it defines are case sensitive

-   What filters can be used in value sets that use the code system in a ValueSet.compose element

-   What concept properties are defined by the code system

::: {.callout-caution collapse="true"}
## Expand to view an example of a simple `CodeSystem` FHIR resource

``` json
{
  "resourceType" : "CodeSystem",
  "id" : "example",
  "meta" : {
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablecodesystem"]
  },
  "text" : {
    "status" : "additional",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      \n      <p>CodeSystem &quot;ACME Codes for Cholesterol&quot;: This is an example code system that includes \n        all the codes for serum cholesterol defined by ACME inc.</p>\n      \n      <p>Developed by: FHIR project team (example)</p>\n      \n      <p>Published for testing on 28-Jan 2016</p>\n      \n      <p>This code system defines all the ACME codes for serum cholesterol:</p>\n      \n      <table class=\"grid\">\n        \n        <tr>\n          \n          <td>\n            \n            <b>Code</b>\n          \n          </td>\n          \n          <td>\n            \n            <b>Display</b>\n          \n          </td>\n          \n          <td>\n            \n            <b>Definition</b>\n          \n          </td>\n        \n        </tr>\n        \n        <tr>\n          \n          <td>chol-mmol</td>\n          \n          <td>SChol (mmol/L)</td>\n          \n          <td>Serum Cholesterol, in mmol/L</td>\n        \n        </tr>\n        \n        <tr>\n          \n          <td>chol-mass</td>\n          \n          <td>SChol (mg/L)</td>\n          \n          <td>Serum Cholesterol, in mg/L</td>\n        \n        </tr>\n        \n        <tr>\n          \n          <td>chol</td>\n          \n          <td>SChol</td>\n          \n          <td>Serum Cholesterol</td>\n        \n        </tr>\n      \n      </table>\n    \n    </div>"
  },
  "url" : "http://hl7.org/fhir/CodeSystem/example",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.4.642.4.1827"
  },
  {
    "system" : "http://acme.com/identifiers/codesystems",
    "value" : "internal-cholesterol-inl"
  }],
  "version" : "5.0.0-cibuild",
  "name" : "ACMECholCodesBlood",
  "title" : "ACME Codes for Cholesterol in Serum/Plasma",
  "status" : "draft",
  "experimental" : true,
  "date" : "2016-01-28",
  "publisher" : "Acme Co",
  "contact" : [{
    "name" : "FHIR project team",
    "telecom" : [{
      "system" : "url",
      "value" : "http://hl7.org/fhir"
    }]
  }],
  "description" : "This is an example code system that includes all the ACME codes for serum/plasma cholesterol from v2.36.",
  "caseSensitive" : true,
  "content" : "complete",
  "filter" : [{
    "code" : "acme-plasma",
    "description" : "An internal filter used to select codes that are only used with plasma",
    "operator" : ["="],
    "value" : "the value of this filter is either 'true' or 'false'"
  }],
  "concept" : [{
    "code" : "chol-mmol",
    "display" : "SChol (mmol/L)",
    "definition" : "Serum Cholesterol, in mmol/L",
    "designation" : [{
      "use" : {
        "system" : "http://acme.com/config/fhir/codesystems/internal",
        "code" : "internal-label"
      },
      "value" : "From ACME POC Testing"
    }]
  },
  {
    "code" : "chol-mass",
    "display" : "SChol (mg/L)",
    "definition" : "Serum Cholesterol, in mg/L",
    "designation" : [{
      "use" : {
        "system" : "http://acme.com/config/fhir/codesystems/internal",
        "code" : "internal-label"
      },
      "value" : "From Paragon Labs"
    }]
  },
  {
    "code" : "chol",
    "display" : "SChol",
    "definition" : "Serum Cholesterol",
    "designation" : [{
      "use" : {
        "system" : "http://acme.com/config/fhir/codesystems/internal",
        "code" : "internal-label"
      },
      "value" : "Obdurate Labs uses this with both kinds of units..."
    }]
  }]
}
```
:::

### ValueSet

The [ValueSet FHIR Resource](https://build.fhir.org/valueset.html) specifies a set of codes drawn from one or more code systems intended for use in a particular context. It uses the `CodeSystem` FHIR Resource by directly referring to it based on whatever code system it is specifying codes from.

::: {.callout-caution collapse="true"}
## Expand to view an example of a `ValueSet` FHIR Resource that specifies the value set of "All CPT Values" from the code system SNOMED CT

``` json
{
  "resourceType" : "ValueSet",
  "id" : "example-cpt-all",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <ul>\n        <li>Include all codes defined in \n          <a href=\"http://terminology.hl7.org/5.1.0/CodeSystem-CPT.html\">\n            <code>http://www.ama-assn.org/go/cpt</code>\n          </a>\n        </li>\n      </ul>\n    </div>"
  },
  "url" : "http://hl7.org/fhir/ValueSet/example-cpt-all",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.4.642.3.3138"
  }],
  "version" : "5.0.0-cibuild",
  "name" : "AllCPTCodes",
  "title" : "All CPT codes",
  "status" : "active",
  "experimental" : true,
  "date" : "2015-03-12",
  "publisher" : "Health Level Seven International (Vocabulary)",
  "description" : "A value set that includes all CPT codes",
  "useContext" : [{
    "code" : {
      "system" : "http://example.org/fhir/CodeSystem/use-contexts",
      "code" : "species"
    },
    "valueCodeableConcept" : {
      "coding" : [{
        "system" : "http://snomed.info/sct",
        "code" : "337915000",
        "display" : "Homo sapiens (organism)"
      }]
    }
  }],
  "jurisdiction" : [{
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    }]
  }],
  "copyright" : "CPT Copyright © 2014 American Medical Association. All rights reserved.",
  "compose" : {
    "include" : [{
      "system" : "http://www.ama-assn.org/go/cpt"
    }]
  }
}
```
:::

### ConceptMap

The [`ConceptMap` FHIR Resource](https://build.fhir.org/conceptmap.html) provides a one-way mapping between a set of concepts that are defined in a code system. In FHIR, this mapping is intended to be for a particular use case, which should be defined by the specification. The example below maps SNOMED CT to ICD-10, which is a use case that is common in data analysis and billing.

::: {.callout-caution collapse="true"}
## Expand to view an example of a `ConceptMap` FHIR Resource that maps SNOMED CT to ICD-10

``` json
{
  "resourceType" : "ConceptMap",
  "id" : "103",
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>SNOMEDCTToICD10CMMappingsForFractureOfUlna (http://hl7.org/fhir/ConceptMap/103)</h2>\n      <p>Mapping from http://snomed.info/sct?fhir_vs to (not specified)</p>\n      <p>DRAFT (not intended for production usage). Published on 2012-06-13 by HL7, Inc (FHIR project team (example): \n        <a href=\"http://hl7.org/fhir\">http://hl7.org/fhir</a>). Creative Commons 0\n      </p>\n      <div>\n        <p>Example rule-based mappings between SNOMED CT to ICD-10-CM for fracture of ulna</p>\n\n      </div>\n      <br/>\n      <p>\n        <b>Group 1</b>Mapping from \n        <a href=\"http://terminology.hl7.org/5.1.0/CodeSystem-v3-snomed-CT.html\">SNOMED\u00a0CT International Edition</a> to \n        <a href=\"http://terminology.hl7.org/5.1.0/CodeSystem-icd10CM.html\">International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM)</a>\n      </p>\n      <table class=\"grid\">\n        <tr>\n          <td>\n            <b>Source Code</b>\n          </td>\n          <td>\n            <b>Relationship</b>\n          </td>\n          <td>\n            <b>Target Code</b>\n          </td>\n          <td>\n            <b>Comment</b>\n          </td>\n        </tr>\n        <tr>\n          <td>263204007 (Fracture of shaft of ulna)</td>\n          <td>\n            <a href=\"codesystem-concept-map-relationship.html#source-is-broader-than-target\" title=\"source-is-broader-than-target\">is broader than</a>\n          </td>\n          <td>S52.209A (Unsp fracture of shaft of unsp ulna, init for clos fx)</td>\n          <td>The target mapping to ICD-10-CM is 'source-is-broader-than-target', since additional patient data on the encounter (initial vs. subsequent) and fracture type is required for a valid ICD-10-CM mapping.</td>\n        </tr>\n        <tr>\n          <td>263204007 (Fracture of shaft of ulna)</td>\n          <td>\n            <a href=\"codesystem-concept-map-relationship.html#source-is-broader-than-target\" title=\"source-is-broader-than-target\">is broader than</a>\n          </td>\n          <td>S52.209D (Unsp fx shaft of unsp ulna, subs for clos fx w routn heal)</td>\n          <td>The target mapping to ICD-10-CM is 'source-is-broader-than-target', since additional patient data on the encounter (initial vs. subsequent), fracture type and healing (for subsequent encounter) is required for a valid ICD-10-CM mapping.</td>\n        </tr>\n      </table>\n    </div>"
  },
  "url" : "http://hl7.org/fhir/ConceptMap/103",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.4.642.14.7"
  },
  {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:uuid:53cd62ee-033e-414c-9f58-3ca97b5ffc3b"
  }],
  "version" : "5.0.0-cibuild",
  "name" : "SNOMEDCTToICD10CMMappingsForFractureOfUlna",
  "title" : "SNOMED CT to ICD-10-CM mappings for fracture of ulna",
  "status" : "draft",
  "experimental" : true,
  "date" : "2012-06-13",
  "publisher" : "HL7, Inc",
  "contact" : [{
    "name" : "FHIR project team (example)",
    "telecom" : [{
      "system" : "url",
      "value" : "http://hl7.org/fhir"
    }]
  }],
  "description" : "Example rule-based mappings between SNOMED CT to ICD-10-CM for fracture of ulna",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
      "code" : "840",
      "display" : "United States of America"
    }]
  }],
  "purpose" : "Show example rule based mappings",
  "copyright" : "Creative Commons 0",
  "sourceScopeCanonical" : "http://snomed.info/sct?fhir_vs",
  "group" : [{
    "source" : "http://snomed.info/sct",
    "target" : "http://hl7.org/fhir/sid/icd-10-cm",
    "element" : [{
      "code" : "263204007",
      "target" : [{
        "code" : "S52.209A",
        "relationship" : "source-is-broader-than-target",
        "comment" : "The target mapping to ICD-10-CM is 'source-is-broader-than-target', since additional patient data on the encounter (initial vs. subsequent) and fracture type is required for a valid ICD-10-CM mapping."
      }]
    },
    {
      "code" : "263204007",
      "target" : [{
        "code" : "S52.209D",
        "relationship" : "source-is-broader-than-target",
        "comment" : "The target mapping to ICD-10-CM is 'source-is-broader-than-target', since additional patient data on the encounter (initial vs. subsequent), fracture type and healing (for subsequent encounter) is required for a valid ICD-10-CM mapping."
      }]
    }]
  }]
}
```
:::
